PVLAPalvella Therapeutics, Inc.

$125.31+71% 1Y

$125.31

$70.4352 weeks$158.19

Is the business good?

Watch

Margins compressing. That is the only one of 4 checks this filer's data supports, so take it as a single data point rather than a settled answer.

1 to watch, 3 without data

Margin direction, 3 years−1344.5 ptsderived

Operating margin has narrowed over the past few years, profitability per dollar of sales is eroding.

Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.

The closest names by size in the same industry